Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.

被引：0
|
作者：
Wimalasingham, Akhila Ganeshi
Lista, Alfonso Gomez de Liano
de Bruijn, Roderick
Haanen, John B. A. G.
Szabados, Bernadett
Hall, Peter
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] THE OUTCOME OF PATIENTS TREATED WITH UPFRONT SUNITINIB PRIOR TO NEPHRECTOMY IN METASTATIC CLEAR CELL RENAL CANCER
    Powles, T.
    Blank, C.
    Chowdhury, S.
    Peters, J.
    Haanen, J.
    O'Brien, T.
    Rockall, A. R.
    Sahdev, A. S.
    Nichol, D.
    Boleti, K.
    Irfan, I.
    Horenblas, S.
    Bex, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 102 - 103
  • [2] The safety and efficacy of pazopanib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Boleti, Ekaterini
    Sarwar, Naveed
    Jones, Robert R.
    Chowdhury, Simon
    Crabb, Simon J.
    Shamash, Jonathan
    Peters, John
    Oades, Grenville
    O'Brien, Tim S.
    Berney, Dan
    Rockall, Andrea
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [3] Dynamic molecular changes with VEGF targeted therapy in metastatic clear cell renal cancer
    Powles, Thomas
    Sharpe, Kevin
    Berney, Dan
    Kayani, Irfan
    Doshi, Rukma
    Stewart, Grant Duncan
    Reynolds, Andrew
    Bex, Axel
    Sarwar, Naveed
    Chowdhury, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [4] Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
    Powles, Thomas
    Sarwar, Naveed
    Stockdale, Andrew
    Sarker, Shah-Jalal
    Boleti, Ekaterini
    Protheroe, Andrew
    Jones, Robert
    Chowdhury, Simon
    Peters, John
    Oades, Grenville
    O'Brien, Tim
    Sullivan, Mark
    Aitchison, Michael
    Beltran, Luis
    Worth, Daniel
    Smith, Kate
    Michel, Constance
    Trevisan, Giorgia
    Harvey-Jones, Elizabeth
    Wimalasingham, Akhila
    Sahdev, Anju
    Ackerman, Charlotte
    Crabb, Simon
    JAMA ONCOLOGY, 2016, 2 (10) : 1303 - 1309
  • [5] Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis
    Xuwei Hong
    Fei Li
    Kaiqiang Tang
    Shiyu Pang
    Guangzheng Lin
    Shi Li
    Jiming Bao
    Wanlong Tan
    International Urology and Nephrology, 2016, 48 : 967 - 975
  • [6] Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis
    Hong, Xuwei
    Li, Fei
    Tang, Kaiqiang
    Pang, Shiyu
    Lin, Guangzheng
    Li, Shi
    Bao, Jiming
    Tan, Wanlong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (06) : 967 - 975
  • [7] Utilization and sequencing of targeted therapy and cytoreductive nephrectomy in non-clear cell metastatic kidney cancer.
    Macleod, Liam Connor
    Tykodi, Scott S.
    Holt, Sarah
    Gore, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] SURVIVAL FOLLOWING UPFRONT CYTOREDUCTIVE NEPHRECTOMY VERSUS TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA
    Bhindi, Bimal
    Habermann, Elizabeth
    Mason, Ross
    Costello, Brian
    Pagliaro, Lance
    Thompson, R. Houston
    Leibovich, Bradley
    Boorjian, Stephen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E486 - E486
  • [9] The safety and efficacy of sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C. U.
    Chowdhury, S.
    Horenblas, S.
    Sarwar, N.
    Nathan, P. D.
    Boleti, E.
    Haanen, J. B.
    Bex, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis
    Chen, Bo
    Li, Jinze
    Huang, Yin
    Tang, Bo
    Jiang, Jinjiang
    Chen, Zeyu
    Li, Jin
    Wang, Puze
    Cao, Dehong
    Liu, Liangren
    Wei, Qiang
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 982 - 994
12345